# Metabolic Podcast Questions

**URL:** <https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352>\
**Category:** Medical Q&A \[Moderated\]\
**Created:** [March 30, 2023, 5:58pm UTC](https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352 "2023-03-30T17:58:12Z")\
**Posts on this page:** 6\
**Page:** 1

<div class="post-metadata">

**Author:** ![easwara](https://sea1.discourse-cdn.com/flex001/user_avatar/forum.barbellmedicine.com/easwara/32/4933_2.png) [@easwara](https://forum.barbellmedicine.com/u/easwara)\
**Post date:** [March 30, 2023, 5:58pm UTC](https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352/1 "2023-03-30T17:58:12Z")

</div>

Hello Docs,

Thanks for this platform and the contents u all generate. Whenever there are extreme claims on health topic I always stop here to get a  
clarification. Thanks for the evidence based approach. Back to my question

I am 48 Male South Asian decent with a Family History of Cardio Vascular diseases.

For metabolic syndrome

- I know currently Fasting glucose \< 100 is the norm. On the podcast Austin mentioned about having a OGTT for 1 Hr as Criteria (May be a wish list )  
What is the OGTT Normal value for 30 mins and 60 mins .

- Also TG \<100 and BP 120/80 is that also a part of the little more proactive measurement instead of TG \<150 and BP 130/80

- What would be an ideal LDL-C or Apob Target ? . Currenlty my Apob is 72 and LDL-C is 96 with 5 mg Rosuvastatin.

I have a Primary appointment coming up ,based on your current articles for lipids seems like Lower lipids over longer period of time is better  
But I am not sure how much low is better and from Medication Increasing statin Or Combining with Statin/ezetimibe works better in reducing the  
values better.

Appreciate all of the information’s shared in your platform

Thanks  
Easwara

---

<div class="post-metadata">

**Author:** ![Austin\_Baraki](https://sea1.discourse-cdn.com/flex001/user_avatar/forum.barbellmedicine.com/austin_baraki/32/1095_2.png) [@Austin\_Baraki](https://forum.barbellmedicine.com/u/Austin_Baraki)\
**Post date:** [March 30, 2023, 6:35pm UTC](https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352/2 "2023-03-30T18:35:37Z")

</div>

1. I would use a 1-hour cutoff of 155 mg/dL (8.6 mmol/L), as discussed [here](https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00039-6/fulltext) and [here](https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(18)31463-3/pdf).

2. Yes, that represents stricter, more “proactive” cutoffs. For example, even when I see triglycerides of 140 mg/dL I do have some concern about a degree of insulin resistance going on, especially if HDL-c is low as well.

3. Unfortunately this is getting a bit more into the realm of a consultation, as I do not have enough information to provide comprehensive recommendations here. For “primary prevention” (i.e., a person who has never had a cardiovascular event, does not have known cardiovascular disease, and is not otherwise at exceptionally high risk), an ApoB target of less than around 80 mg/dL is reasonable, although if lower levels can be achieved easily, it would confer incrementally lower long-term risk. Statin dose escalation comes with further, albeit diminishing returns (see [here](https://pbs.twimg.com/media/FOadL3sXoAM5A7t.png)), so if further lowering is desired that is one option, versus combining low-dose rosuvastatin with ezetimibe.

---

<div class="post-metadata">

**Author:** ![easwara](https://sea1.discourse-cdn.com/flex001/user_avatar/forum.barbellmedicine.com/easwara/32/4933_2.png) [@easwara](https://forum.barbellmedicine.com/u/easwara)\
**Post date:** [April 1, 2023, 12:08am UTC](https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352/3 "2023-04-01T00:08:06Z")

</div>

Thanks Dr Austin for your response. Few follow-up on the LDL part if u can answer

- Do u have a similar LDL-c reduction chart for Statin/ezetimibe combination ?

- I have attached a chart

with percentile Vs Apob values . For a primary prevention for low/medium/High risk under what percentile we should target Apob Is there any data like that ?

Thanks for all of your responses .

[ATTACH=JSON]{“data-align”:“none”,“data-size”:“medium”,“data-tempid”:“temp\_1353\_1680307615380\_737”}[/ATTACH]

Thanks  
Easwara

---

<div class="post-metadata">

**Author:** ![easwara](https://sea1.discourse-cdn.com/flex001/user_avatar/forum.barbellmedicine.com/easwara/32/4933_2.png) [@easwara](https://forum.barbellmedicine.com/u/easwara)\
**Post date:** [April 1, 2023, 1:13am UTC](https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352/4 "2023-04-01T01:13:21Z")

</div>

Also forgot to ask one more thing Once we start statin do u see any relevance of checking CAC test for every 5 years ?​

---

<div class="post-metadata">

**Author:** ![Austin\_Baraki](https://sea1.discourse-cdn.com/flex001/user_avatar/forum.barbellmedicine.com/austin_baraki/32/1095_2.png) [@Austin\_Baraki](https://forum.barbellmedicine.com/u/Austin_Baraki)\
**Post date:** [April 1, 2023, 3:32am UTC](https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352/5 "2023-04-01T03:32:30Z")

</div>

> [@easwara](#):
>
> Thanks Dr Austin for your response. Few follow-up on the LDL part if u can answer
> 
> - Do u have a similar LDL-c reduction chart for Statin/ezetimibe combination ?

No, I am not aware of this kind of data given that ezetimibe is only dosed at 10 mg (despite the fact that it shows similar dose-response effect from 1 mg to 5 mg to 10 mg). However there are trial data comparing higher-dose statin against lower-dose statin plus ezetimibe ( [Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial - PubMed](https://pubmed.ncbi.nlm.nih.gov/35863366/) ).

> [@easwara](#):
>
> I have attached a chart with percentile Vs Apob values . For a primary prevention for low/medium/High risk under what percentile we should target Apob Is there any data like that ?

I do not see an attached chart, but generally target less than 90 mg/dL in general, less than 80 mg/dL for high risk patients, and as low as possible for secondary prevention patients (or those continuing to have cardiovascular events despite treatment).

> Also forgot to ask one more thing Once we start statin do u see any relevance of checking CAC test for every 5 years ?​​

No, I would not do this.

---

<div class="post-metadata">

**Author:** ![easwara](https://sea1.discourse-cdn.com/flex001/user_avatar/forum.barbellmedicine.com/easwara/32/4933_2.png) [@easwara](https://forum.barbellmedicine.com/u/easwara)\
**Post date:** [April 2, 2023, 12:36pm UTC](https://forum.barbellmedicine.com/t/metabolic-podcast-questions/13352/6 "2023-04-02T12:36:01Z")

</div>

Thanks Dr Austin for taking your valuable time and responding to my questions . Appreciate that .
